BPC-157

BPC-157 is a stable synthetic pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a region of human gastric juice protein BPC. It has demonstrated pleiotropic tissue-protective effects in preclinical models, including acceleration of tendon, ligament, and muscle healing; gastroprotection and intestinal mucosal repair; modulation of nitric oxide synthesis and VEGF-mediated angiogenesis; and neuroprotection in CNS injury models. Its high stability in biological environments and broad receptor interaction profile make it one of the most extensively studied peptides in regenerative medicine research. Available in 5mg (BP.05) and 10mg (BP.10) vials.

Molecular Information

Quality Assurance & Supplier Commitment

We maintain longstanding relationships with leading peptide lyophilizers and raw material suppliers, selected through an exhaustive vetting process that evaluates manufacturing practices, analytical capabilities, and regulatory compliance. Our API sourcing protocol includes certificate of analysis review, third-party analytical testing, and periodic supplier audits to ensure consistent purity, potency, and sterility standards across all product lines.

Each batch undergoes meticulous quality control verification prior to release, including HPLC purity analysis, mass spectrometry confirmation, and endotoxin testing where applicable. Our commitment to sourcing integrity ensures researchers receive material of the highest available quality.